Strides Pharma Science gets EIR for Bangalore facility
23rd Jul 2019

Strides Pharma Science has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its formulations facility (KRSG Gardens) in Bangalore, thereby confirming the successful closure of the inspections. The facility was inspected by the USFDA in May 2019.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.